Skip to main content
. Author manuscript; available in PMC: 2014 Nov 10.
Published in final edited form as: J Control Release. 2013 May 3;171(3):349–357. doi: 10.1016/j.jconrel.2013.04.018

Figure 1.

Figure 1

A schematic representation of Nanostructured Lipid Carrier (NLC)-based drug delivery system for pulmonary co-delivery of an anticancer drug, siRNA and targeting peptide.